Fast, local cryopreservation is a consistent bottleneck for autologous cell therapy developers, even in major cell and gene therapy hubs.
Many applications including cell therapy require removing white blood cells from leukapheresis products. When performed manually, this process can be laborious and subject to user error, which leads ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results